NASDAQ$ULBI

Ultralife Corporation · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Ultralife reported increased sales and operating income, with medical sales reaching a record high and adjusted EPS turning positive.

Ultralife Corporation reported a strong fourth quarter with a 23.4% increase in sales, driven by growth in both government/defense and commercial sectors. The company's operating income significantly improved, and adjusted EPS turned positive. Battery & Energy Products saw growth in commercial sales, particularly in medical batteries, while Communications Systems benefited from shipments to defense contractors.

  • Sales increased by 23.4% year-over-year, reaching $44.5 million.
  • Operating income rose to $3.6 million, compared to $0.2 million in the same quarter of the previous year.
  • Adjusted EPS was $0.18, a significant improvement from a loss of $0.03 in the fourth quarter of 2022.
  • Medical sales reached the highest quarterly level in the company's history.

Headline financials

Total Revenue

$44.5M

Previous: $36.1M+23.4%
EPS (adj)

$0.18

Previous: -$0.01+1900.0%
Gross Margin

25.6%

No prior period
Adjusted EBITDA

$4.77M

Previous: $2M+138.6%
Adjusted EBITDA Margin

10.7%

No prior period
Capital Expenditures

$1.01M

Previous: $283K+255.1%
Net Income

$2.9M

Previous: -$200K+1550.0%
Operating Income

$3.6M

Previous: $200K+1700.0%
Gross Profit

$11.4M

Previous: $8.1M+40.7%
R&D Expense

$1.85M

No prior period
Stock-Based Comp

$104K

Previous: $224K-53.6%

Revenue & EPS history

Ultralife · Revenue · Quarterly

$44.5M

Q4 2023+23.4%vs Q4 2022
Beat estimate in 7 of 14 quarters(50%)
ActualEstimate

Revenue by segment

Ultralife · $7.6M total across 1 segment · Q3 2023

  • Communications Systems
    $7.6M+61.7%

Forward guidance

Ultralife is focused on driving additional gross margin expansion, organic growth in end markets and operating leverage. They will continue to invest in new product development for commercial expansion. Their focus in 2024 is to build upon their 2023 momentum, sustain profitable growth and generate incremental cash flow to reduce debt, and support strategic capital expenditures and accretive acquisitions.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+5.4%

Avg return

30 days after

46%

30 / 65 earnings

Positive

+56.6%

Q2 2023

Best reaction

-26.7%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-14.3%-16.4%-4.6%
Q4 2025+8.3%+22.9%+28.5%
Q3 2025-9.0%-5.4%+4.7%
Q1 2025+2.9%+13.1%+57.8%
Q4 2024-6.1%-16.0%-18.2%
Q3 2024-14.3%-16.5%-18.3%
Q2 2024-3.1%-4.1%-1.8%
Q1 2024+30.5%+34.0%+29.4%
Q4 2023+16.5%+11.6%+6.6%
Q3 2023-22.3%-19.3%-18.2%
Q2 2023+56.6%+70.8%+87.4%
Q1 2023+3.6%-1.2%+4.9%
Q4 2022+0.5%-3.2%-0.2%
Q3 2022-4.6%-7.1%-15.4%
Q2 2022-4.1%-1.9%+8.8%
Q1 2022+6.4%+3.9%+7.1%
Q4 2021-7.4%-9.1%+0.9%
Q3 2021-9.3%-7.4%-19.9%
Q2 2021-6.3%-4.8%-5.3%
Q1 2021-1.4%-3.5%+14.0%
Q4 2020+8.2%+24.6%+11.9%
Q3 2020-9.8%-6.5%+20.1%
Q2 2020+1.7%+1.0%-9.7%
Q1 2020+7.6%+19.7%+19.3%
Q4 2019+11.4%+12.7%+0.0%
Q3 2019-7.1%-5.5%-6.4%
Q2 2019+6.0%-1.8%-1.8%
Q1 2019-18.1%-23.2%-30.0%
Q4 2018+4.1%+12.9%+26.1%
Q3 2018+10.9%+9.7%+8.4%
Q2 2018-3.5%-1.0%-13.5%
Q1 2018+3.3%+0.0%+12.1%
Q4 2017+7.6%+8.3%+19.7%
Q3 2017-14.3%-12.2%-12.9%
Q2 2017-2.2%-4.3%-6.5%
Q1 2017+7.2%+6.3%+20.7%
Q4 2016-1.0%+6.9%+8.8%
Q3 2016-7.8%-8.9%+6.7%
Q2 2016-7.6%-13.8%-11.0%
Q1 2016-11.0%
Q4 2015-4.5%
Q3 2015+5.3%
Q2 2015+0.0%
Q1 2015+1.5%
Q4 2014+9.7%
Q3 2014+5.7%
Q2 2014-8.3%
Q1 2014+7.2%
Q4 2013-5.2%
Q3 2013-4.5%
Q2 2013-0.3%
Q1 2013+1.8%
Q4 2012+11.2%
Q3 2012+5.9%
Q2 2012-26.7%
Q1 2011+0.5%
Q1 2012-1.0%
Q4 2011+0.6%
Q4 2009+0.6%
Q3 2011-3.0%
Q3 2010-3.0%
Q4 2010-0.2%
Q2 2010-0.2%
Q2 2011-0.2%
Q1 2010+4.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro